Jean-François Turcotte

Lessard DA, Huard-Girard T, Tremblay A, Turcotte JF

Transition to oral antibiotic therapy for pyelonephritis in children under 60 days of age: An observational retrospective cohort study

Paediatr Child Health, 26 (1), 2021.

Résumé | Liens:

Dufour LA, Plaisance M, Turcotte JF

A 5-month-old with failure to thrive

Paediatr Child Health, 23 (8), 2018.

| Liens:

Yang H, Al-Hertani W, Cyr D, Laframboise R, Parizeault G, Wang SP, Rossignol F, Berthier MT, Giguere Y, Waters PJ, Mitchell GA,

Hypersuccinylacetonaemia and normal liver function in maleylacetoacetate isomerase deficiency

J Med Genet, 54 (4), 2017.

Résumé | Liens:

, Alvarez F, Atkinson S, Bouchard M, Brunel-Guitton C, Buhas D, Bussieres JF, Dubois J, Fenyves D, Goodyer P, Gosselin M, Halac U, Labbe P, Laframboise R, Maranda B, Melancon S, Merouani A, Mitchell GA, Mitchell J, Parizeault G, Pelletier L, Phan V, Turcotte JF

The Québec NTBC Study

Adv Exp Med Biol, 959 , 2017.

Résumé | Liens:

Zaidi D, Bording-Jorgensen M, Huynh HQ, Carroll MW, Turcotte JF, Sergi C, Liu J, Wine E

Increased Epithelial Gap Density in the Noninflamed Duodenum of Children With Inflammatory Bowel Diseases

J Pediatr Gastroenterol Nutr, 63 (6), 2016.

Résumé | Liens:

Turcotte JF, Kao D, Mah SJ, Claggett B, Saltzman JR, Fedorak RN, Liu JJ

Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos)

Gastrointest Endosc, 77 (4), 2013.

Résumé | Liens:

Turcotte JF, Wong K, Mah SJ, Dieleman LA, Kao D, Kroeker K, Claggett B, Saltzman JR, Wine E, Fedorak RN, Liu JJ

Increased epithelial gaps in the small intestine are predictive of hospitalization and surgery in patients with inflammatory bowel disease

Clin Transl Gastroenterol, 3 , 2012.

Résumé | Liens:

Turcotte JF, Prasil P, Gagnon P, Castilloux J

Case 1: Recurrent iron-deficiency anemia in a teenager

Paediatr Child Health, 17 (1), 2012.

| Liens:

Turcotte JF, Huynh HQ

Treatment with the probiotic VSL#3 as an adjunctive therapy in relapsing mild-to-moderate ulcerative colitis significantly reduces ulcerative colitis disease activity

Evid Based Med, 16 (4), 2011.

| Liens: